Annual report pursuant to Section 13 and 15(d)

Fair Value Measurement (Details 1)

v2.4.0.6
Fair Value Measurement (Details 1) (Fair Value, Measurements, Recurring [Member], USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Assets:    
Total assets $ 31,694 $ 70,077
Liabilities:    
Total Liabilities 30,159 18,002
Common stock investments [Member]
   
Assets:    
Total assets 8,236  
Certificates of Deposit [Member]
   
Assets:    
Total assets 820  
Quoted prices in active markets for identical assets (Level 1) [Member]
   
Assets:    
Total assets 26,952 68,089
Quoted prices in active markets for identical assets (Level 1) [Member] | Common stock investments [Member]
   
Assets:    
Total assets 8,236  
Significant other observable inputs (Level 2) [Member]
   
Assets:    
Total assets 2,702 1,988
Significant other observable inputs (Level 2) [Member] | Certificates of Deposit [Member]
   
Assets:    
Total assets 820  
Significant unobservable inputs (Level 3) [Member]
   
Assets:    
Total assets 2,040  
Liabilities:    
Total Liabilities 30,159 18,002
Deferred acquisition payments, net of discount [Member]
   
Liabilities:    
Total Liabilities 10,103  
Deferred acquisition payments, net of discount [Member] | Significant unobservable inputs (Level 3) [Member]
   
Liabilities:    
Total Liabilities 10,103  
CURNA Contingent consideration [Member]
   
Liabilities:    
Total Liabilities 510 510
CURNA Contingent consideration [Member] | Significant unobservable inputs (Level 3) [Member]
   
Liabilities:    
Total Liabilities 510 510
OPKO Diagnostics Contingent Consideration [Member]
   
Liabilities:    
Total Liabilities 12,974 12,745
OPKO Diagnostics Contingent Consideration [Member] | Significant unobservable inputs (Level 3) [Member]
   
Liabilities:    
Total Liabilities 12,974 12,745
FineTech Contingent consideration [Member]
   
Liabilities:    
Total Liabilities 5,262 4,747
FineTech Contingent consideration [Member] | Significant unobservable inputs (Level 3) [Member]
   
Liabilities:    
Total Liabilities 5,262 4,747
Farmadiet Contingent consideration [Member]
   
Liabilities:    
Total Liabilities 1,310  
Farmadiet Contingent consideration [Member] | Significant unobservable inputs (Level 3) [Member]
   
Liabilities:    
Total Liabilities 1,310  
Money market funds [Member]
   
Assets:    
Total assets 18,716 68,089
Money market funds [Member] | Quoted prices in active markets for identical assets (Level 1) [Member]
   
Assets:    
Total assets 18,716 68,089
Forward contracts [Member]
   
Assets:    
Total assets 10 143
Forward contracts [Member] | Significant other observable inputs (Level 2) [Member]
   
Assets:    
Total assets 10 143
Neovasc common stock options [Member]
   
Assets:    
Total assets 1,394 1,031
Neovasc common stock options [Member] | Significant other observable inputs (Level 2) [Member]
   
Assets:    
Total assets 1,394 1,031
Neovasc common stock warrants [Member]
   
Assets:    
Total assets 478 814
Neovasc common stock warrants [Member] | Significant other observable inputs (Level 2) [Member]
   
Assets:    
Total assets 478 814
Notes conversion feature [Member] | BZNE [Member]
   
Assets:    
Total assets 2,040  
Notes conversion feature [Member] | Significant unobservable inputs (Level 3) [Member] | BZNE [Member]
   
Assets:    
Total assets $ 2,040